Pfizer raises 2021 sales forecast for Covid vaccines to $26 bn
Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher Covid-19 vaccine sales as it targets the inoculations as a “durable” revenue stream.